PharmaShots | Incisive News in 3 Shots

Subscribe Now

Avastin

Roche Reports Updated OS Data of Tecentriq + Avastin in P-III IMbrave150 Study for Unresectable HCC

Roche Reports Updated OS Data of Tecentriq + Avastin in P-III IMbrave150 Study for Unresectable HCC

January 12, 2021

Chugai's Tecentriq (atezolizumab) and Avastin (bevacizumab) Receive MHLW's Approval as 1L Treatment for Unresectable Hepatocellular Carcinoma

Chugai's Tecentriq (atezolizumab) and Avastin (bevacizumab) Receive MHLW's Approval as 1L Treatment for Unresectable Hepatocellula...

September 28, 2020

Top 20 Prescription Drugs Based on 2019 Revenue

Top 20 Prescription Drugs Based on 2019 Revenue

July 17, 2020

Insights+ Key Biosimilars Events of August 2019

Insights+ Key Biosimilars Events of August 2019

September 9, 2019

Cipla Signs an Exclusive License Agreement with Bio-Thera for its BAT1706 (bevacizumab- biosimilar)

Cipla Signs an Exclusive License Agreement with Bio-Thera for its BAT1706 (bevacizumab- biosimilar)

January 15, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us